Professor Tadashi Yamamoto, head of the Cell Signal Unit at the Okinawa Institute of Science and Technology (OIST), has been selected as the recipient ...
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that multiple abstracts ...
Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies ...
Verismo Therapeutics, a clinical-stage immuno-oncology company developing a novel multi-chain KIR-CAR platform technology, ...
UAB is participating in a Phase I/II trial of AMT 191, a one time gene therapy designed to enable patients with classic Fabry disease to produce their own missing enzyme, potentially reducing the need ...
The age on your driver's license may not be the same age as the cells in your body. Scientists use something called an ...
Everyone’s favorite bracket challenge has returned. That’s right—it’s time once again for Fierce Pharma Marketing’s annual ...
Researchers have identified a distinct and reproducible gene expression program associated with neurotransmission in the living human brain, offering unprecedented insight into the molecular ...
An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results